151 related articles for article (PubMed ID: 35621677)
1. Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach.
Hanly P; Ortega-Ortega M; Soerjomataram I
Curr Oncol; 2022 May; 29(5):3552-3564. PubMed ID: 35621677
[TBL] [Abstract][Full Text] [Related]
2. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
Hanly P; Soerjomataram I; Sharp L
Int J Cancer; 2015 Feb; 136(4):E136-45. PubMed ID: 25066804
[TBL] [Abstract][Full Text] [Related]
3. Advances in the methodological approach to friction period estimation: A European perspective.
Hanly P; Ortega Ortega M; Pearce A; Soerjomataram I; Sharp L
Soc Sci Med; 2020 Nov; 264():113289. PubMed ID: 32836019
[TBL] [Abstract][Full Text] [Related]
4. Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.
Pike J; Grosse SD
Appl Health Econ Health Policy; 2018 Dec; 16(6):765-778. PubMed ID: 30094591
[TBL] [Abstract][Full Text] [Related]
5. Valuing productivity costs in a changing macroeconomic environment: the estimation of colorectal cancer productivity costs using the friction cost approach.
Hanly P; Koopmanschap M; Sharp L
Eur J Health Econ; 2016 Jun; 17(5):553-61. PubMed ID: 26022915
[TBL] [Abstract][Full Text] [Related]
6. Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach.
Hanly P; Timmons A; Walsh PM; Sharp L
Value Health; 2012 May; 15(3):429-36. PubMed ID: 22583452
[TBL] [Abstract][Full Text] [Related]
7. Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches.
Pearce AM; Hanly P; Timmons A; Walsh PM; O'Neill C; O'Sullivan E; Gooberman-Hill R; Thomas AA; Gallagher P; Sharp L
Appl Health Econ Health Policy; 2015 Aug; 13(4):359-67. PubMed ID: 25691128
[TBL] [Abstract][Full Text] [Related]
8. Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries.
Hanly P; Ortega Ortega M; Pearce A; de Camargo Cancela M; Soerjomataram I; Sharp L
Pharmacoeconomics; 2023 Sep; 41(9):1093-1101. PubMed ID: 37036642
[TBL] [Abstract][Full Text] [Related]
9. The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study.
Hanly P; Ahern M; Sharp L; Ursul D; Loughnane G
Eur J Health Econ; 2022 Mar; 23(2):249-259. PubMed ID: 34417904
[TBL] [Abstract][Full Text] [Related]
10. Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Appl Health Econ Health Policy; 2023 Nov; 21(6):877-889. PubMed ID: 37552416
[TBL] [Abstract][Full Text] [Related]
11. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Int J Cancer; 2022 Feb; 150(4):580-593. PubMed ID: 34569617
[TBL] [Abstract][Full Text] [Related]
12. Friction cost approach methodology in pharmacoeconomic analyses.
Grega D; Kolář J
Ceska Slov Farm; 2021; 70(3):109-113. PubMed ID: 34418948
[TBL] [Abstract][Full Text] [Related]
13. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden.
Hanly PA; Sharp L
BMC Cancer; 2014 Mar; 14():224. PubMed ID: 24670067
[TBL] [Abstract][Full Text] [Related]
14. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
Henderson RH; French D; Maughan T; Adams R; Allemani C; Minicozzi P; Coleman MP; McFerran E; Sullivan R; Lawler M
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):709-722. PubMed ID: 34329626
[TBL] [Abstract][Full Text] [Related]
15. The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018.
Rumgay H; Ortega-Ortega M; Sharp L; Lunet N; Soerjomataram I
Cancer Epidemiol; 2023 Jun; 84():102365. PubMed ID: 37058915
[TBL] [Abstract][Full Text] [Related]
16. Variation in the methodological approach to productivity cost valuation: the case of prostate cancer.
Hanly P; Maguire R; Drummond F; Sharp L
Eur J Health Econ; 2019 Dec; 20(9):1399-1408. PubMed ID: 31444674
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs.
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Maciejczyk A; Popovic L; Karamousouli E; Salomonsson S
J Med Econ; 2023; 26(1):254-261. PubMed ID: 36756852
[TBL] [Abstract][Full Text] [Related]
18. Indirect Costs Due to Lung Cancer-Related Premature Mortality in Four European Countries.
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Salomonsson S; Demedts I
Adv Ther; 2023 Jul; 40(7):3056-3069. PubMed ID: 37195488
[TBL] [Abstract][Full Text] [Related]
19. The Lost Productivity Cost of Premature Mortality Owing to Cancers in Iran: Evidence From the GLOBOCAN 2012 to 2018 Estimates.
Nahvijou A; Daroudi R; Javan-Noughabi J; Dehdarirad H; Faramarzi A
Value Health Reg Issues; 2022 Sep; 31():1-9. PubMed ID: 35313156
[TBL] [Abstract][Full Text] [Related]
20. Productivity Loss Across Socioeconomic Groups Among Patients With Low Back Pain or Osteoarthritis: Estimates Using the Friction-Cost Approach in Norway.
Hansen JAL; Fast T; Wangen KR
Pharmacoeconomics; 2023 Sep; 41(9):1079-1091. PubMed ID: 37084066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
